Mike J. Pishvaian, MD, PhD
Advertisement
Mike J. Pishvaian, MD, PhD, is director of Gastrointestinal, Developmental Therapeutics and Clinical Research Programs and an associate professor of oncology at Johns Hopkins Medicine in Baltimore, Maryland.
Articles by Mike J. Pishvaian, MD, PhD
Advertisement
Advertisement
Advertisement
Trending on OncLive
1
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
2
FDA Updates Axi-Cel Label to Remove Limitation of Use in R/R PCNSL
3
Real-World Data Support Clinical Benefit With Lifileucel in Previously Treated Advanced Melanoma
4
Nonresponse to Bridging Therapy and Peak ALC After Cilta-Cel Are Associated With Neurotoxicity, NRM in Myeloma
5